Skip to main content

A clearer way to understand peptides.

Research listings · Peptides

Sermorelin research listings: prices and suppliers

Research materials and consumer products belong to different categories. A listing, laboratory report, or research-use label does not establish suitability for personal use.

We have no commercial relationship with suppliers on this page. Offers are sorted by price per mg; commission never changes the order.

Prices observed weekly · last check · How we check prices →

Lowest current at 2 mg × 1 vial$12.98 / mg · $25.95Swiss Chems · checked 5 days ago

Listings at 2 mg × 1 vial

Current Sermorelin listings at 2 mg × 1 vial (column headings with arrows can be selected to sort)
Supplier link
Swiss ChemsProduct page includes use or preparation wording2 mg × 1 vial$25.95$12.98 / mgIn stock5 d agoNot linkedView product details (opens in a new tab)No commercial relationship
Amino USAProduct page includes use or preparation wording2 mg × 1 vial$30.00$15.00 / mgLow stock5 d agoNot linkedView product details (opens in a new tab)No commercial relationship
  • Swiss ChemsProduct page includes use or preparation wordingIn stock

    Sermorelin · 2 mg × 1 vial

    $25.95$12.98 / mg

    Checked · 5 days ago

    Lab report: Not linked

  • Amino USAProduct page includes use or preparation wordingLow stock

    Sermorelin · 2 mg × 1 vial

    $30.00$15.00 / mg

    Checked · 5 days ago

    Lab report: Not linked

By size

Every package size we track for Sermorelin. Current means seen in the last 8 days.

Sermorelin listings by package size (column headings with arrows can be selected to sort)
2 mg × 1 vial$25.95$12.98 / mg2 / 22
5 mg × 1 vial$43.00$8.60 / mg10 / 109
10 mg × 1 vial$45.00$4.50 / mg3 / 53
15 mg × 1 vial$100.00$6.67 / mg1 / 11
5 mg × 10 vials$408.00$8.16 / mg2 / 22

Research context

From our own records, with the date each was last checked.

FDA approval
Geref (sermorelin acetate) was approved under NDAs 019863 (1990-12-28) and 020443 (1997-09-26); both discontinued, approvals withdrawn at the holder's request effective 2009-06-18Checked
503A / 503B compounding
Not in any 503A category on FDA's 2026-05-14 listChecked
Advisory committee (PCAC)
No PCAC meeting on sermorelin found on FDA's 2022 to 2027 PCAC meeting pages (checked 2026-11-03)Checked
Rulemaking / enforcement
No FDA rule found (search on 2026-11-03); matching rules are CMS Medicare payment rules with a sermorelin billing code. A 2013-03-04 FDA notice: Geref not withdrawn for safety or effectivenessChecked
WADA
S2.2.4 Growth hormone releasing factors: GHRH and its analogues · Prohibited at all times — in and out of competition (2026 list; unchanged in the 2027 list, in force from Jan 1, 2027)Checked
Identity
Formula C149H246N44O42S · MW 3357.9 g/mol · CAS 86168-78-7Sequence YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2Source record Checked

Identity noteNot the same molecule as CJC-1295 without DAC (modified GRF 1-29), which differs at four positions. Research listings are not FDA-approved medicines.

How we check prices · Offers are matched to our catalogue by an editor before they appear; a listing is not an endorsement.